摘要
BACKGROUND Stem cells from apical papilla(SCAPs)represent promising candidates for bone regenerative therapies due to their osteogenic potential.However,enhancing their differentiation capacity remains a critical challenge.Enhancer of zeste homolog 2(EZH2),a histone H3 lysine 27 methyltransferase,regulates osteogenesis through epigenetic mechanisms,but its role in SCAPs remains unclear.We hypothesized that EZH2 modulates SCAP osteogenic differentiation via interaction with lysine demethylase 2B(KDM2B),offering a target for therapeutic intervention.AIM To investigate the functional role and molecular mechanism of EZH2 in SCAP osteogenic differentiation.METHODS SCAPs were isolated from healthy human third molars(n=6 donors).Osteogenic differentiation was assessed via Alizarin red staining and alkaline phosphatase assays.EZH2 overexpression/knockdown models were established using lentiviral vectors.Protein interactions were analyzed by co-immunoprecipitation,transcriptomic changes via microarray(Affymetrix platform),and chromatin binding by chromatin immunoprecipitation-quantitative polymerase chain reaction.In vivo bone formation was evaluated in immunodeficient mice(n=8/group)transplanted with SCAPs-hydroxyapatite scaffolds.Data were analyzed using Student’s t-test and ANOVA.RESULTS EZH2 overexpression increased osteogenic markers and mineralized nodule formation.In vivo,EZH2-overexpressing SCAPs generated 10%more bone/dentin-like tissue.Co-immunoprecipitation confirmed EZH2-KDM2B interaction,and peptide-mediated disruption of this binding enhanced osteogenesis.Transcriptome analysis identified 1648 differentially expressed genes(971 upregulated;677 downregulated),with pathway enrichment in Wnt/β-catenin signaling.CONCLUSION EZH2 promotes SCAP osteogenesis via antagonistic interaction with KDM2B,and targeted disruption of this axis offers a translatable strategy for bone regeneration.
基金
Supported by National Key Research and Development Program,No.2022YFA1104401
Beijing Natural Science Foundation,No.7222075
CAMS Innovation Fund for Medical Sciences,No.2019RU020
Innovation Research Team Project of Beijing Stomatological Hospital,No.CXTD202204.
